Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The efficacy and safety of metformin for addressing neurocognitive dysfunction in schizophrenia remain inconclusive. This systematic review evaluates the evidence from randomized controlled trials (RCTs) on the effects of metformin on neurocognitive function in patients with schizophrenia.

Methods: A comprehensive search of Chinese databases (WanFang, Chinese Journal Net) and English databases (PubMed, EMBASE, PsycINFO, and Cochrane Library) was conducted to identify RCTs assessing metformin's impact on neurocognitive outcomes in schizophrenia.

Results: Four RCTs involving 271 patients with schizophrenia were included. Three RCTs (75%) demonstrated significant improvements in neurocognitive function with metformin compared to controls, as assessed by the MATRICS Consensus Cognitive Battery, Repeatable Battery for the Assessment of Neuropsychological Status, and Mini-Mental State Examination, but not the Brief Assessment of Cognition in Schizophrenia. Two RCTs (50%) evaluated metformin's effects on total psychopathology and found no significant differences between groups. Adverse events were reported in two RCTs, with inconsistent findings on decreased appetite and diarrhea. Other adverse events and discontinuation rates were comparable between groups.

Conclusion: Preliminary evidence suggests that metformin may improve neurocognitive function in schizophrenia. However, further large-scale, double-blind, high quality RCTs are warranted to validate these findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788895PMC
http://dx.doi.org/10.3389/fpsyt.2024.1540153DOI Listing

Publication Analysis

Top Keywords

neurocognitive function
12
metformin neurocognitive
8
neurocognitive dysfunction
8
dysfunction schizophrenia
8
systematic review
8
adverse events
8
rcts
7
metformin
5
schizophrenia
5
neurocognitive
5

Similar Publications

Slowing down the clock on ovarian aging-does the ovary hold the secret to the fountain of youth?

Geroscience

September 2025

NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

In the past century, the human Lifespan has doubled. However, this is not equivalent to Healthspan which refers to the number of years spent healthy and free from disease. Women have an additional level of complexity on the path to optimal healthspan where health resilience dramatically decreases following menopause and this is due to their ovaries aging by midlife.

View Article and Find Full Text PDF

Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.

View Article and Find Full Text PDF

Imprints of extreme prematurity on functional brain networks in school-aged children and adolescents.

Neuroimage

September 2025

Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland; Advanced Magnetic Imaging Centre, Aalto University School of Science, Espoo, Finland. Electronic address:

Cognitive functions emerge from dynamic functional interplay of cortical and subcortical areas that form networks. Preterm birth poses a risk for the formation and functionality of brain networks which may lead to severe brain dysfunctions. Infants born extremely preterm have the highest risk of developing neurocognitive impairments.

View Article and Find Full Text PDF

Effectiveness and safety of adjunctive transcranial direct current stimulation for adolescents with first-episode major depressive disorder: A randomized, double-blind, sham-controlled trial.

J Affect Disord

September 2025

The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou, China. Electronic address:

Background: Transcranial direct current stimulation (tDCS), a non-invasive brain stimulation method, can improve depressive symptoms by applying weak electric direct currents to the scalp. This study aimed to evaluate the efficacy and safety of adjunctive tDCS for adolescents with first-episode major depressive disorder (FE-MDD).

Methods: This double-blind, randomized, sham-controlled trial (RCT) was conducted between January 3, 2024, and August 24, 2024.

View Article and Find Full Text PDF

Importance: Higher intellectual abilities have been associated with lower mortality risk in several longitudinal cohort studies. However, these studies did not fully account for early life contextual factors or test whether the beneficial associations between higher neurocognitive functioning and mortality extend to children exposed to early adversity.

Objective: To explore how the associations of child neurocognition with mortality changed according to the patterns of adversity children experienced.

View Article and Find Full Text PDF